3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
24
Lung Neoplasms
12
Prostatic Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Breast Neoplasms
5
Stomach Neoplasms
4
Prostatic Neoplasms, Castration-Resistant
4
Neoplasms
4
Endometrial Neoplasms
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Melanoma
2
Lymphoid Interstitial Pneumonia
2
Head and Neck Neoplasms
2
HER2-positive Breast Cancer
2
Esophageal Neoplasms
2
Anatomic Stage I Breast Cancer AJCC v8
2
Vaccinia
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Tongue Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Solid Tumors
1
Interventions
Magnetic Resonance Spectroscopy
7
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Temozolomide
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Cyclophosphamide
2
Cisplatin
2
tazemetostat
1
pembrolizumab
1
palbociclib
1
lutetium Lu 177 dotatate
1
Vemurafenib
1
Vascular Endothelial Growth Factor A
1
Triiodothyronine
1
Thiotepa
1
Radiotherapy
1
Radiation
1
Platinum
1
Pharmacogenomic Variants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Docetaxel
×
30 days
×
Clear all
No trials found.